Ognomy Inc. — SEC Form D Filing

Ognomy Inc. filed an SEC Form D on May 26, 2026, reporting $14.90M raised in Health Care.

Form D filing details

Filing
SEC Form D
Filing date
May 26, 2026
Amount reported
$14.90M
Round stage
Series A
Industry
Health Care
Website
https://www.ognomy.com/

What the company does

Securities: Equity. Exemption: Rule 506(b). Incorporated: DELAWARE

Problem

Obstructive Sleep Apnea (OSA) is a common sleep disorder where blocked airways during sleep lead to paused breathing and oxygen deprivation, resulting in serious health issues. A significant challenge is that 80% of sufferers go undiagnosed, leading to untreated consequences.

Solution

Ognomy Sleep provides comprehensive virtual sleep apnea care through a nationwide virtual platform. They offer at-home sleep tests, telemedicine consultations, and various therapies, including CPAP, oral appliances, Inspire® implant, and weight management with GLP-1 medications.

Why now

With the rise of telehealth and the urgent need for accessible healthcare solutions, Ognomy addresses a critical gap in sleep apnea treatment.

Verdict

Investors said yes because Ognomy tapped into a pressing need for accessible obstructive sleep apnea solutions amid a growing telehealth trend, not because traditional methods have proven inadequate. They implicitly bet on the scalability of virtual healthcare, especially given the substantial undiagnosed patient pool. However, the limited upside lies in battling entrenched competitors and the potential for regulatory hurdles, which could diminish long-term durability.

Source: SEC EDGAR Form D filing